Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$0.65 USD
-0.01 (-1.53%)
Updated May 1, 2024 03:25 PM ET
After-Market: $0.66 +0.01 (1.54%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (73 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.35 | 9.99 |
Current Quarter Estimate | -0.17 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.19 | 0.12 | 52.54 |
Next Quarter Estimate | -0.15 | 7.81 | 61.00 |
Next Year Estimate | -0.62 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -9.84 | 12.60 | 17.08 |
Next Year | 7.46 | 7.70 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.76 | 1.99 |
Price/Cash Flow (MRFY) | NA | 14.06 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 1.76% |
Return on Equity (TTM) | -115.79% | -12.43% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.